Mérieux Equity Partners, a venture capital and growth equity investments company, completed the investment in Labquality, a provider of multinational clinical trials for pharma, biotech, and medical device companies. Financial terms were not disclosed. "I am excited to see MxEP investing in Labquality. Labquality's values align with Institut Mérieux and MxEP, building a solid foundation for our future business. MxEP has extensive expertise in investing within the global life sciences and healthcare sectors. Having MxEP as part of our team enables us to leverage the Labquality platform to its fullest potential for international expansion," Juha-Pekka Nuutinen, Labquality CEO.